MX2014001028A - Farmaco basado en levomilnacipran para recuperacion funcional despues de eventos neurologicos agudos. - Google Patents
Farmaco basado en levomilnacipran para recuperacion funcional despues de eventos neurologicos agudos.Info
- Publication number
- MX2014001028A MX2014001028A MX2014001028A MX2014001028A MX2014001028A MX 2014001028 A MX2014001028 A MX 2014001028A MX 2014001028 A MX2014001028 A MX 2014001028A MX 2014001028 A MX2014001028 A MX 2014001028A MX 2014001028 A MX2014001028 A MX 2014001028A
- Authority
- MX
- Mexico
- Prior art keywords
- levomilnacipran
- drug
- functional rehabilitation
- acute neurological
- dextromilnacipran
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere al uso de levomilnacipran como producto medicinal en recuperación funcional después de un accidente cerebrovascular o lesión cerebral traumática. Las composiciones farmacéuticas que contienen levomilnacipran son exclusivamente aquellas que no contienen dextromilnacipran a una proporción de más de 5% en peso de la mezcla de levomilnacipran/dextromilnacipran, para evitar comprometer la recuperación funcional debido a la propiedad de bloqueo de alfal del dextromilnacipran.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1156917A FR2978350B1 (fr) | 2011-07-28 | 2011-07-28 | Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu |
| PCT/EP2012/064764 WO2013014263A1 (fr) | 2011-07-28 | 2012-07-27 | Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014001028A true MX2014001028A (es) | 2014-03-27 |
Family
ID=46598516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014001028A MX2014001028A (es) | 2011-07-28 | 2012-07-27 | Farmaco basado en levomilnacipran para recuperacion funcional despues de eventos neurologicos agudos. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20140179794A1 (es) |
| EP (1) | EP2736503B1 (es) |
| JP (1) | JP2014521627A (es) |
| KR (1) | KR20140050668A (es) |
| CN (1) | CN103702666A (es) |
| AR (1) | AR087365A1 (es) |
| AU (1) | AU2012288808A1 (es) |
| BR (1) | BR112014001961A2 (es) |
| CA (1) | CA2843037A1 (es) |
| FR (1) | FR2978350B1 (es) |
| IL (1) | IL230642A0 (es) |
| MA (1) | MA35418B1 (es) |
| MX (1) | MX2014001028A (es) |
| RU (1) | RU2014106661A (es) |
| TN (1) | TN2014000032A1 (es) |
| TW (1) | TW201311232A (es) |
| WO (1) | WO2013014263A1 (es) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2752732B1 (fr) | 1996-08-28 | 1998-11-20 | Pf Medicament | Forme galenique a liberation prolongee de milnacipran |
| US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
| AU2003213009A1 (en) | 2002-02-12 | 2003-09-04 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
| US20030203055A1 (en) | 2002-03-15 | 2003-10-30 | Cypress Bioscience, Inc. | Methods of treating visceral pain syndromes |
| CN1662231A (zh) | 2002-04-24 | 2005-08-31 | 柏树生物科学公司 | 包括应激相关障碍在内的功能性躯体障碍的预防与治疗 |
| MXPA05000566A (es) | 2002-07-24 | 2005-08-29 | Cypress Bioscience Inc | Tratamiento de depresion secundaria al dolor (dsp). |
| AU2003284005B2 (en) | 2002-10-03 | 2009-12-17 | Forest Laboratories Holdings Limited | Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
| WO2004045718A2 (en) | 2002-11-20 | 2004-06-03 | Cypress Bioscience, Inc. | Treatment of cognitive dysfunctions' |
| WO2004075886A1 (fr) * | 2003-02-14 | 2004-09-10 | Pierre Fabre Medicament | Utilisation de l’enantiomere (1s, 2r) du milnacipran pour la preparation d’un medicament |
| FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
| AU2005260955A1 (en) | 2004-07-14 | 2006-01-19 | Astellas Pharma Inc. | Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| US7994220B2 (en) | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| US20080058318A1 (en) | 2006-08-09 | 2008-03-06 | Cypress Bioscience, Inc. | Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia |
| US20080058317A1 (en) | 2006-08-09 | 2008-03-06 | Cypress Bioscience, Inc. | Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| TW200911225A (en) | 2007-05-22 | 2009-03-16 | Cypress Bioscience Inc | Methods for improving physical function in fibromyalgia |
| EP2110129A1 (en) | 2008-04-18 | 2009-10-21 | Pierre Fabre Medicament | Use of enantiomer (1S, 2R) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| CA2790933A1 (en) * | 2010-01-14 | 2011-07-21 | Forest Laboratories Holdings Limited | Stable dosage forms of levomilnacipran |
-
2011
- 2011-07-28 FR FR1156917A patent/FR2978350B1/fr not_active Expired - Fee Related
-
2012
- 2012-07-27 AU AU2012288808A patent/AU2012288808A1/en not_active Abandoned
- 2012-07-27 TW TW101127255A patent/TW201311232A/zh unknown
- 2012-07-27 AR ARP120102747A patent/AR087365A1/es unknown
- 2012-07-27 RU RU2014106661/15A patent/RU2014106661A/ru not_active Application Discontinuation
- 2012-07-27 CN CN201280036763.0A patent/CN103702666A/zh active Pending
- 2012-07-27 KR KR1020147004197A patent/KR20140050668A/ko not_active Application Discontinuation
- 2012-07-27 CA CA2843037A patent/CA2843037A1/fr not_active Abandoned
- 2012-07-27 US US14/235,303 patent/US20140179794A1/en not_active Abandoned
- 2012-07-27 BR BR112014001961A patent/BR112014001961A2/pt not_active IP Right Cessation
- 2012-07-27 JP JP2014522107A patent/JP2014521627A/ja active Pending
- 2012-07-27 MX MX2014001028A patent/MX2014001028A/es not_active Application Discontinuation
- 2012-07-27 EP EP12740965.4A patent/EP2736503B1/fr not_active Not-in-force
- 2012-07-27 WO PCT/EP2012/064764 patent/WO2013014263A1/fr active Application Filing
-
2014
- 2014-01-21 TN TNP2014000032A patent/TN2014000032A1/fr unknown
- 2014-01-26 IL IL230642A patent/IL230642A0/en unknown
- 2014-02-25 MA MA36782A patent/MA35418B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2978350B1 (fr) | 2013-11-08 |
| TW201311232A (zh) | 2013-03-16 |
| US20140179794A1 (en) | 2014-06-26 |
| MA35418B1 (fr) | 2014-09-01 |
| RU2014106661A (ru) | 2015-09-10 |
| CA2843037A1 (fr) | 2013-01-31 |
| AR087365A1 (es) | 2014-03-19 |
| WO2013014263A1 (fr) | 2013-01-31 |
| EP2736503A1 (fr) | 2014-06-04 |
| EP2736503B1 (fr) | 2015-07-08 |
| NZ621474A (en) | 2015-02-27 |
| BR112014001961A2 (pt) | 2017-02-21 |
| TN2014000032A1 (fr) | 2015-07-01 |
| JP2014521627A (ja) | 2014-08-28 |
| AU2012288808A1 (en) | 2014-03-13 |
| IL230642A0 (en) | 2014-03-31 |
| FR2978350A1 (fr) | 2013-02-01 |
| KR20140050668A (ko) | 2014-04-29 |
| CN103702666A (zh) | 2014-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180102B1 (ar) | مركب صيدلاني | |
| IN2014DN09805A (es) | ||
| PH12016500094A1 (en) | Autotaxin inhibitors | |
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| WO2013179307A3 (en) | Stabilized pharmaceutical compositions of saxagliptin | |
| MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
| NZ631601A (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
| JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| IN2014DN09804A (es) | ||
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| MX362879B (es) | Usos novedosos. | |
| CY1121238T1 (el) | Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων | |
| UA117154C2 (uk) | Антагоністи s1p3 | |
| PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
| SG10201907291QA (en) | Monomethylfumarate prodrug compositions | |
| PH12015500704A1 (en) | Pharmaceutical composition comprising rebamipide | |
| IN2015MN00064A (es) | ||
| MX2017008074A (es) | DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß). | |
| WO2014172363A3 (en) | Combretastatin analogs | |
| PH12017500005A1 (en) | Tricyclic triazolic compounds | |
| MX2017008076A (es) | DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß. | |
| IN2014MN01492A (es) | ||
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |